Literature DB >> 19921787

The Caulerpa pigment caulerpin inhibits HIF-1 activation and mitochondrial respiration.

Yang Liu1, J Brian Morgan, Veena Coothankandaswamy, Rui Liu, Mika B Jekabsons, Fakhri Mahdi, Dale G Nagle, Yu-Dong Zhou.   

Abstract

The transcription factor hypoxia-inducible factor-1 (HIF-1) represents an important molecular target for anticancer drug discovery. In a T47D cell-based reporter assay, the Caulerpa spp. algal pigment caulerpin (1) inhibited hypoxia-induced as well as 1,10-phenanthroline-induced HIF-1 activation. The angiogenic factor vascular endothelial growth factor (VEGF) is regulated by HIF-1. Caulerpin (10 microM) suppressed hypoxic induction of secreted VEGF protein and the ability of hypoxic T47D cell-conditioned media to promote tumor angiogenesis in vitro. Under hypoxic conditions, 1 (10 microM) blocked the induction of HIF-1alpha protein, the oxygen-regulated subunit that controls HIF-1 activity. Reactive oxygen species produced by mitochondrial complex III are believed to act as a signal of cellular hypoxia that leads to HIF-1alpha protein induction and activation. Further mechanistic studies revealed that 1 inhibits mitochondrial respiration at electron transport chain (ETC) complex I (NADH-ubiquinone oxidoreductase). Under hypoxic conditions, it is proposed that 1 may disrupt mitochondrial ROS-regulated HIF-1 activation and HIF-1 downstream target gene expression by inhibiting the transport or delivery of electrons to complex III.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921787      PMCID: PMC2798910          DOI: 10.1021/np9005794

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  36 in total

Review 1.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing.

Authors:  Robert D Guzy; Beatrice Hoyos; Emmanuel Robin; Hong Chen; Liping Liu; Kyle D Mansfield; M Celeste Simon; Ulrich Hammerling; Paul T Schumacker
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

5.  Constituents of Chondria armata.

Authors:  M B Govenkar; S Wahidulla
Journal:  Phytochemistry       Date:  2000-08       Impact factor: 4.072

Review 6.  Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilization.

Authors:  M Celeste Simon
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

7.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

8.  Molecular-targeted antitumor agents. 19. Furospongolide from a marine Lendenfeldia sp. sponge inhibits hypoxia-inducible factor-1 activation in breast tumor cells.

Authors:  Yang Liu; Rui Liu; Shui-Chun Mao; J Brian Morgan; Mika B Jekabsons; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2008-11-06       Impact factor: 4.050

9.  Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1.

Authors:  Tyler W Hodges; Chowdhury Faiz Hossain; Yong-Pil Kim; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2004-05       Impact factor: 4.050

10.  Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo.

Authors:  Leiming Li; Xiaoyu Lin; Alex R Shoemaker; Daniel H Albert; Stephen W Fesik; Yu Shen
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

View more
  13 in total

1.  Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.

Authors:  Sandipan Datta; Thomas Sears; Gino Cortopassi; Kevin Woolard; James M Angelastro
Journal:  Biomed Pharmacother       Date:  2020-12-08       Impact factor: 6.529

Review 2.  Marine macroalga Caulerpa: role of its metabolites in modulating cancer signaling.

Authors:  Richa Mehra; Satej Bhushan; Felix Bast; Sandeep Singh
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

3.  Kalkitoxin inhibits angiogenesis, disrupts cellular hypoxic signaling, and blocks mitochondrial electron transport in tumor cells.

Authors:  J Brian Morgan; Yang Liu; Veena Coothankandaswamy; Fakhri Mahdi; Mika B Jekabsons; William H Gerwick; Frederick A Valeriote; Yu-Dong Zhou; Dale G Nagle
Journal:  Mar Drugs       Date:  2015-03-20       Impact factor: 5.118

Review 4.  The Mitochondrial Complex(I)ty of Cancer.

Authors:  Félix A Urra; Felipe Muñoz; Alenka Lovy; César Cárdenas
Journal:  Front Oncol       Date:  2017-06-08       Impact factor: 6.244

5.  Fishing for Targets of Alien Metabolites: A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Agonist from a Marine Pest.

Authors:  Rosa Maria Vitale; Enrico D'Aniello; Stefania Gorbi; Andrea Martella; Cristoforo Silvestri; Maria Elisa Giuliani; Tariq Fellous; Alessandra Gentile; Marianna Carbone; Adele Cutignano; Laura Grauso; Laura Magliozzi; Gianluca Polese; Biagio D'Aniello; Fanny Defranoux; Serena Felline; Antonio Terlizzi; Antonio Calignano; Francesco Regoli; Vincenzo Di Marzo; Pietro Amodeo; Ernesto Mollo
Journal:  Mar Drugs       Date:  2018-11-03       Impact factor: 5.118

Review 6.  Anti-inflammatory activity of alkaloids: an update from 2000 to 2010.

Authors:  Augusto Lopes Souto; Josean Fechine Tavares; Marcelo Sobral da Silva; Margareth de Fátima Formiga Melo Diniz; Petrônio Filgueiras de Athayde-Filho; José Maria Barbosa Filho
Journal:  Molecules       Date:  2011-10-11       Impact factor: 4.411

Review 7.  From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds.

Authors:  Celso Alves; Joana Silva; Susete Pinteus; Helena Gaspar; Maria C Alpoim; Luis M Botana; Rui Pedrosa
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

8.  Spasmolytic effect of caulerpine involves blockade of Ca²⁺ influx on guinea pig ileum.

Authors:  Luiz Henrique Agra Cavalcante-Silva; Ana Carolina de Carvalho Correia; José Maria Barbosa-Filho; Bagnólia Araújo da Silva; Bárbara Viviana de Oliveira Santos; Daysianne Pereira de Lira; Jéssica Celestino Ferreira Sousa; George Emmanuel C de Miranda; Fabiana de Andrade Cavalcante; Magna Suzana Alexandre-Moreira
Journal:  Mar Drugs       Date:  2013-05-13       Impact factor: 5.118

9.  Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells.

Authors:  Claudia Calabrese; Luisa Iommarini; Ivana Kurelac; Maria Antonietta Calvaruso; Mariantonietta Capristo; Pier-Luigi Lollini; Patrizia Nanni; Christian Bergamini; Giordano Nicoletti; Carla De Giovanni; Anna Ghelli; Valentina Giorgio; Mariano Francesco Caratozzolo; Flaviana Marzano; Caterina Manzari; Christine M Betts; Valerio Carelli; Claudio Ceccarelli; Marcella Attimonelli; Giovanni Romeo; Romana Fato; Michela Rugolo; Apollonia Tullo; Giuseppe Gasparre; Anna Maria Porcelli
Journal:  Cancer Metab       Date:  2013-03-18

Review 10.  Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity.

Authors:  Djenisa H A Rocha; Ana M L Seca; Diana C G A Pinto
Journal:  Mar Drugs       Date:  2018-10-26       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.